home / stock / atra / atra articles
Over the past twenty days of trading, Atara Biotherapeutics Inc. (NASDAQ: ATRA), from September 20, 2019 to October 17, 2019 there is a potential S...
Atara Biotherapeutics Inc. Company Name:
ATRA Stock Symbol:
NASDAQ Market:
Atara Biotherapeutics Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
Overall Response Rate (ORR) of 60% Observed in Patients with Relapsed or Refractory (R/R) EBV+ PTLD Consistent with Previously Reported Studies Completion of All Pre-Approval Inspections Required to Support EU Marketing Authorization Application; Anticipated European Commissio...
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that it received notification of Bayer’s intenti...
FDA Fast-Track Designated ATA188 Interim Analysis On-Track for June 2022 Tab-cel Anticipated European Commission Approval On-Track for Q4 2022; Dialogue with FDA Ongoing Cash Expected to Fund Planned Operations into Q4 2023 with Sale of Cell Therapy Manufacturing Facil...